A polymerphism of the angiorensin-converting enzyme gene according to the asthma severity.
- Author:
Jae Youn CHO
;
Dae Ryoung CHA
;
Seon Ae HAN
;
Sang Yeub LEE
;
Shin Hyung LEE
;
Sea Yong KANG
;
Jae Jeong SHIM
;
Kyeong Ho KANG
;
Se Hwa YOO
;
Kwang Ho IN
- Publication Type:Original Article
- Keywords:
ACE gene;
polymorphism;
asthma severity
- MeSH:
Angiotensin II;
Asthma*;
Bradykinin;
Education;
Genotype;
Humans;
Inflammation;
Muscle, Smooth;
Polymerase Chain Reaction;
Polymorphism, Genetic;
Substance P;
Tachykinins
- From:Journal of Asthma, Allergy and Clinical Immunology
1998;18(4):656-661
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The angiotensin-converting enzyme (ACE) has a major role in the degradation of bradykinin, tachykinin, substance P which are associated with bronchial hyperresponsiveness and inflammation. The other role of ACE is the genesis of angiotensin II which causes bronchial smooth muscle contraction. The deletion polymorphism of ACE gene(DDtype) may be related to the high serum level of ACE. OBJECTIVE: We studied to evaluate an association between the insertion /deletion polymorphism of the ACE gene and asthma, and its severity. Materials and methods: Sixty asthmatic patients and 44 healthy controls were enrolled. Severity of asthma was classified by the guideline of NHLBI/WHO workshop. The ACE genotypes of all the subjects were determined by polymerase chain reaction. RESULTS: The distribution of ACE genotypes were not significantly different between healthy controls and asthma group (p)0.05). In asthmatic patients, the genetic polymorphism was similar between different severity groups (p) 0.05). Conchcsion: It is suggested that I/D polymorphism of the ACE gene may not be associated with development of asthma. The severity of asthma may not be influenced by I/D polymorphism of the ACE gene.
